Retia Medical Earns 2026 Frost & Sullivan Recognition for Innovation in Hemodynamic Monitoring
WHITE PLAINS, NEW YORK, UNITED STATES, April 28 2026 — Retia Medical has received the 2026 Frost & Sullivan Technology Innovation Leadership Recognition in the Global Hemodynamic Monitoring Industry.
Presented by Frost & Sullivan, a globally recognized research and consulting firm, the award honors companies demonstrating strong innovation and measurable impact in their markets. This year’s recognition highlights Retia Medical’s performance across key best-practices criteria in hemodynamic monitoring, under the theme of enhancing customer impact through powerful technology integration.
The recognition reflects Retia’s continued focus on delivering accurate, reliable cardiovascular intelligence to clinicians and supporting care for high-risk surgical and critically ill patients.